Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Technology Scientific & Technical Instruments
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Applied DNA Announces Closing of $4.2 Million Registered Direct Offering

Business Wire February 24, 2022

Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering

Business Wire February 22, 2022

Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA(TM) Platform Approach to Cancer Immunotherapy

Business Wire February 17, 2022

Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues

Business Wire February 10, 2022

Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022

Business Wire February 3, 2022

Applied DNA to Deploy Linea(TM) 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2

Business Wire January 28, 2022

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea(TM) 2.0 COVID-19 Assay and Linea(TM) Unsupervised At-Home Sample Collection Kit

Business Wire January 21, 2022

Applied DNA Announces Continued Momentum in COVID-19 Testing Demand

Business Wire January 18, 2022

Applied DNA Receives New York State Department of Health Conditional Approval for Linea(TM) 2.0 COVID-19 Assay as Laboratory Developed Test

Business Wire January 4, 2022

Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance

Business Wire December 15, 2021

Applied DNA Reports Fourth Quarter and Full Fiscal Year 2021 Financial Results, Continuing Momentum in Diagnostic Testing

Business Wire December 9, 2021

Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance

Business Wire December 6, 2021

Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021

Business Wire December 3, 2021

Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea(TM) 2.0 COVID-19 Assay Kit

Business Wire November 29, 2021

Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer

Business Wire November 15, 2021

Research Publication Demonstrates Utility of Applied DNA's LinearDNA(TM) in Non-Viral CAR T Manufacturing Systems

Business Wire November 9, 2021

Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing

Business Wire November 5, 2021

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea(TM) SARS-CoV-2 Mutation Panel

Business Wire October 25, 2021

Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain

Business Wire October 20, 2021

Applied DNA Implements safeCircle(TM) COVID-19 Testing Program at Sarah Lawrence College

Business Wire October 12, 2021